Insulin Lispro Protamin/Lispro
Brand name: Humalog Mix 75-25 Kwikpen
Rank #218 of 500 drugs by total cost
$62.8M
Total Cost
60,873
Total Claims
$62.8M
Total Cost
2,872
Prescribers
$1,032
Cost per Claim
4,249
Beneficiaries
90,766
30-Day Fills
$22K
Avg Cost/Provider
21
Avg Claims/Provider
About Insulin Lispro Protamin/Lispro
Insulin Lispro Protamin/Lispro (sold as Humalog Mix 75-25 Kwikpen) was prescribed 60,873 times by 2,872 Medicare Part D providers in 2023, costing the program $62.8M. At $1,032 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 215 | Canagliflozin (Invokana) | $63.7M | 66,550 |
| 216 | Belimumab (Benlysta) | $63.4M | 13,386 |
| 217 | Collagenase Clostridium Hist. (Santyl) | $63.3M | 70,641 |
| 218 | Insulin Lispro Protamin/Lispro (Humalog Mix 75-25 Kwikpen) | $62.8M | 60,873 |
| 219 | Furosemide (Furosemide) | $62.3M | 9,788,207 |
| 220 | Buprenorphine (Buprenorphine) | $61.1M | 156,598 |
| 221 | Ferric Citrate (Auryxia) | $60.7M | 32,798 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology